Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 109.44%12.71B | -71.91%6.07B | 54.47%21.61B | 27.22%13.99B | 12.07%11B | -46.81%9.81B | 33.06%18.44B | -5.37%13.86B | 8.71%14.65B | 3.69%13.48B |
Net profit before non-cash adjustment | -22.45%15.68B | 28.28%20.22B | 12,024.62%15.76B | -99.00%130M | -36.32%12.98B | -4.88%20.39B | 84.53%21.44B | -23.51%11.62B | -2.30%15.19B | 0.19%15.55B |
Total adjustment of non-cash items | 55.92%6.72B | -18.67%4.31B | -28.29%5.3B | 6,379.82%7.39B | 102.40%114M | -202.35%-4.75B | 10.11%4.64B | -36.51%4.21B | 197.45%6.64B | -0.53%2.23B |
-Depreciation and amortization | 8.43%8.44B | 9.60%7.78B | -3.33%7.1B | -6.02%7.35B | -1.16%7.82B | -2.55%7.91B | 2.64%8.12B | 5.47%7.91B | 13.62%7.5B | 31.43%6.6B |
-Reversal of impairment losses recognized in profit and loss | 1,119.56%7.17B | 258.54%588M | 14.69%164M | -7.74%143M | 9.93%155M | -92.48%141M | 681.25%1.88B | -1.64%240M | -83.96%244M | 263.01%1.52B |
-Share of associates | 42.61%164M | 33.72%115M | 120.14%86M | -890.74%-427M | 80.00%54M | 57.89%30M | 137.50%19M | -33.33%8M | -72.09%12M | 19.44%43M |
-Disposal profit | -561.84%-6.76B | 18.37%-1.02B | -1,355.81%-1.25B | 98.50%-86M | 51.76%-5.72B | -93.76%-11.86B | -73.47%-6.12B | -363.60%-3.53B | 78.93%-761M | -290.06%-3.61B |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | --543M | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 27.34%-2.29B | -293.15%-3.16B | -295.85%-803M | 114.99%410M | -181.77%-2.74B | -229.81%-971M | 280.24%748M | -16.25%-415M | 84.61%-357M | -0.56%-2.32B |
Changes in working capital | 47.52%-9.69B | -3,486.61%-18.46B | -91.57%545M | 406.83%6.47B | 63.87%-2.11B | 23.55%-5.84B | -287.21%-7.63B | 72.54%-1.97B | -66.89%-7.18B | 9.68%-4.3B |
-Change in receivables | 149.70%1.34B | -668.78%-2.7B | -93.11%474M | 563.30%6.88B | -160.10%-1.49B | 302.04%2.47B | 68.23%-1.22B | -868.46%-3.85B | -85.32%501M | 203.80%3.41B |
-Change in inventory | 81.87%-3B | -282.28%-16.55B | -817.16%-4.33B | -116.89%-472M | 131.06%2.79B | -88.73%-9B | -274.39%-4.77B | 133.71%2.73B | -23.33%-8.11B | -492.25%-6.57B |
-Change in payables | -230.81%-5.7B | 5.17%4.36B | 269.34%4.14B | 11.44%-2.45B | -1,196.03%-2.76B | -94.95%252M | 645.20%4.99B | -2,594.12%-916M | 50.72%-34M | 81.10%-69M |
-Provision for loans, leases and other losses | -284.92%-766M | 52.05%-199M | -165.56%-415M | -38.18%633M | 27.05%1.02B | 112.14%806M | -10,804.84%-6.64B | -86.61%62M | 143.27%463M | ---1.07B |
-Changes in other current assets | 53.61%-1.56B | -600.59%-3.37B | -64.07%673M | 211.55%1.87B | -355.01%-1.68B | ---369M | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -23.33%-259M | 36.94%-210M | 23.80%-333M | 34.68%-437M | -14.16%-669M | 0.00%-586M | -94.68%-586M | -20.40%-301M | -29.53%-250M | 11.47%-193M |
Interest received (cash flow from operating activities) | 2.40%2.73B | 62.22%2.66B | -20.11%1.64B | -28.75%2.05B | -2.20%2.88B | 6.93%2.95B | 29.50%2.76B | 7.42%2.13B | 6.22%1.98B | 16.19%1.87B |
Tax refund paid | 19.63%-5.9B | -396.69%-7.35B | 6.63%-1.48B | 85.77%-1.58B | -325.37%-11.13B | 26.65%-2.62B | -45.34%-3.57B | 43.55%-2.46B | 17.49%-4.35B | -40.15%-5.27B |
Other operating cash inflow (outflow) | -1.32%-308M | -258.33%-304M | -61.29%192M | 155.23%496M | -27.74%-898M | 52.50%-703M | -142.62%-1.48B | -610M | 0 | -1M |
Operating cash flow | 929.39%8.97B | -95.97%871M | 48.98%21.63B | 1,131.30%14.52B | -86.68%1.18B | -43.13%8.85B | 23.31%15.57B | 4.93%12.62B | 21.82%12.03B | -7.02%9.88B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -4.81%-7.7B | -66.42%-7.34B | 28.94%-4.41B | 18.32%-6.21B | -34.28%-7.6B | -164.95%-5.66B | 72.46%-2.14B | -30.42%-7.76B | -58.41%-5.95B | 22.67%-3.76B |
Net intangibles purchase and sale | -494.83%-2.07B | -48.09%-348M | 51.35%-235M | -1.26%-483M | 48.38%-477M | -43.93%-924M | 22.18%-642M | -336.51%-825M | 53.33%-189M | -40.14%-405M |
Net business purchase and sale | -1,859.22%-1.81B | 298.08%103M | ---52M | ---- | 129.41%65M | 44.19%-221M | 19.18%-396M | 87.38%-490M | 11.81%-3.88B | -115.73%-4.4B |
Net investment product transactions | 162.68%16.87B | 532.10%6.42B | -145.88%-1.49B | -73.78%3.24B | 25.27%12.35B | 28.68%9.86B | 225.52%7.66B | -1,148.47%-6.11B | -109.47%-489M | 83.81%5.17B |
Advance cash and loans provided to other parties | -30.00%-78M | -25.00%-60M | -77.78%-48M | 50.00%-27M | 88.39%-54M | 6.06%-465M | -4.21%-495M | -41.79%-475M | -97.06%-335M | 19.81%-170M |
Repayment of advance payments to other parties and cash income from loans | -19.23%42M | -92.53%52M | 2,220.00%696M | -72.73%30M | -14.73%110M | -60.55%129M | -18.45%327M | -7.39%401M | 235.66%433M | 230.77%129M |
Net changes in other investments | 14,100.00%142M | -94.74%1M | -42.42%19M | --33M | ---- | -50.00%1M | --2M | ---- | 117.04%46M | -464.86%-270M |
Investing cash flow | 559.06%5.39B | 78.71%-1.18B | -61.47%-5.52B | -177.79%-3.42B | 61.60%4.39B | -37.09%2.72B | 128.33%4.32B | -47.14%-15.25B | -179.43%-10.37B | 17.11%-3.71B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 246.43%23.09B | -110.82%-15.77B | -502.15%-7.48B | 129.97%1.86B | -469.24%-6.21B | 734.34%1.68B | -102.04%-265M | 13,806.32%13.02B | -101.88%-95M | 284.16%5.06B |
Net common stock issuance | -512.59%-30.65B | -99,980.00%-5B | -101.01%-5M | 106.34%497M | -246.62%-7.84B | -32,228.57%-2.26B | 99.42%-7M | 62.20%-1.2B | -635.42%-3.18B | 57.31%-432M |
Cash dividends paid | 2.42%-5.89B | -92.32%-6.04B | 0.06%-3.14B | 50.24%-3.14B | -89.27%-6.31B | -0.18%-3.34B | 0.54%-3.33B | -6.83%-3.35B | 7.53%-3.13B | -17.48%-3.39B |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | --0 | 26.67%-11M | 46.43%-15M | 0.00%-28M | -12.00%-28M |
Net other fund-raising expenses | -3,300.00%-34M | 0.00%-1M | ---1M | ---- | ---- | 200.00%1M | 99.94%-1M | -12.57%-1.59B | -141,500.00%-1.42B | 50.00%-1M |
Financing cash flow | 49.69%-13.49B | -152.34%-26.81B | -1,255.23%-10.63B | 96.15%-784M | -419.99%-20.36B | -8.39%-3.92B | -152.64%-3.61B | 187.45%6.86B | -748.68%-7.85B | 118.14%1.21B |
Net cash flow | ||||||||||
Beginning cash position | -29.53%57.52B | 15.91%81.62B | 19.26%70.42B | -20.87%59.05B | 13.00%74.62B | 29.55%66.04B | 6.61%50.97B | -16.10%47.81B | 25.69%56.99B | 4.81%45.34B |
Current changes in cash | 103.21%871M | -594.44%-27.12B | -46.83%5.48B | 169.74%10.32B | -293.18%-14.79B | -52.96%7.66B | 284.41%16.28B | 168.46%4.23B | -183.85%-6.19B | 1,507.63%7.38B |
Effect of exchange rate changes | 36.50%4.11B | -47.33%3.01B | 262.98%5.72B | 300.38%1.58B | -184.52%-786M | 176.54%930M | -13.23%-1.22B | 64.13%-1.07B | -170.05%-2.99B | 63.98%4.27B |
Cash adjustments other than cash changes | 0.00%1M | --1M | ---- | ---518M | ---- | --1M | ---- | ---- | ---- | 0.00%1M |
End cash Position | 8.66%62.5B | -29.53%57.52B | 15.91%81.62B | 19.26%70.42B | -20.87%59.05B | 13.00%74.62B | 29.55%66.04B | 6.61%50.97B | -16.10%47.81B | 25.69%56.99B |
Free cash flow | 85.64%-1.04B | -146.93%-7.24B | 99.68%15.44B | 208.77%7.73B | -517.81%-7.11B | -84.13%1.7B | 260.75%10.72B | -24.57%2.97B | -26.77%3.94B | 1.64%5.38B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |